Deep Medicine Acquisition Corp. (DMAQR) Stock Analysis

What Deep Medicine Acquisition Corp. does

Deep Medicine Acquisition Corp. currently has no major business operations. The company's principal objective is to complete a strategic transaction, such as a merger, asset acquisition, stock purchase, or other form of corporate reorganization, with one or more existing enterprises. It is specifically focused on identifying potential targets within the healthcare industry. Formed in 2020, the company is headquartered in New York, New York.

Key metrics

ETFs linked to DMAQR

Broad-market and Financial Services sector ETFs an investor holding Deep Medicine Acquisition Corp. is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how DMAQR fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Deep Medicine Acquisition Corp.?

Deep Medicine Acquisition Corp. trades under the ticker DMAQR on NASDAQ.

Which exchange is DMAQR listed on?

DMAQR is listed on NASDAQ.

What sector does Deep Medicine Acquisition Corp. operate in?

Deep Medicine Acquisition Corp. is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze DMAQR in a portfolio?

PortView shows DMAQR's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.